M. Counson

发表

Isolation of an HIV-1 neutralizing peptide mimicking the CXCR4 and CCR5 surface from the heavy-chain complementary determining region 3 repertoire of a viremic controller

J. Schmit, A. Rybicki, C. Seguin-Devaux, 2016, AIDS.

Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.

J. Piette, A. Baragli, J. Hanson, 2016, Biochemical pharmacology.

Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non‐chemokine agonists

J. Steyaert, J. Hanson, M. Meyrath, 2018, Biochemical pharmacology.

Development of Mimokines, chemokine N terminus‐based CXCR4 inhibitors optimized by phage display and rational design

K. Arumugam, A. Mosbah, C. Seguin-Devaux, 2018, Journal of leukocyte biology.

Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection.

J. Schmit, V. Fiévez, M. Szpakowska, 2014, Biochimica et biophysica acta.

Different contributions of chemokine N‐terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3

N. Heveker, B. Volkman, Amanda M. Nevins, 2017, British journal of pharmacology.

Non-immunized natural human heavy chain CDR3 repertoires allow the isolation of high affinity peptides mimicking a human influenza hemagglutinin epitope.

I. Lasters, N. Boutonnet, H. de Haard, 2008, Molecular immunology.

Selection of a CXCR4 antagonist from a human heavy chain CDR3‐derived phage library

J. Schmit, A. Chevigné, M. Counson, 2011, The FEBS journal.

Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.

J. Piette, A. Baragli, J. Hanson, 2016, Biochemical pharmacology.